Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

I-Mab

IMABNASDAQ
Healthcare
Biotechnology
$2.94
$-0.28(-8.70%)
U.S. Market is Open • 13:01

I-Mab (IMAB) Stock Overview

Explore I-Mab’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap240.6M
P/E Ratio-43.35
EPS (TTM)$-0.51
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$6.45
1 Year Target$0.00

IMAB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of I-Mab (IMAB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.55, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -43.35 and a market capitalization of 240.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-8.70%
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-26.32%
6-Month Change
-28.12%
Year-to-Date (YTD) Change
N/A
1-Year Change
250.17%
3-Year Change
-21.18%
5-Year Change
-94.41%
All-Time (Max) Change
-76.48%

Contact Information

240 745 6330
New Bund Center, Rockville, NaN, 200124

Company Facts

320 Employees
IPO DateJan 17, 2020
CountryUS
Actively Trading

Frequently Asked Questions